$MDXG
MIMEDX GROUP, INC. Stock $mdxg

$mdxg Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000137633920000147 Filed on November 04, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$68.55M	$64.30M	$88.86M
YoY Change	-10.28%	-27.64%	2.19%
Cost Of Revenue	$10.82M	$10.29M	$13.21M
YoY Change	-14.87%	-22.08%	79.54%
Gross Profit	$57.73M	$54.01M	$75.66M
YoY Change	-9.36%	-28.61%	-4.96%
Gross Profit Margin	84.22%	84.0%	85.14%
Selling, General & Admin	$48.71M	$48.05M	$51.26M
YoY Change	7.2%	-6.27%	-12.74%
% of Gross Profit	84.38%	88.95%	67.75%
Research & Development	$3.430M	$3.372M	$2.691M
YoY Change	26.1%	25.31%	-32.08%
% of Gross Profit	5.94%	6.24%	3.56%
Depreciation & Amortization	$1.540M	$1.566M	$1.641M
YoY Change	-16.3%	-4.57%	17.21%
% of Gross Profit	2.67%	2.9%	2.17%
Operating Expenses	$52.39M	$51.42M	$53.95M
YoY Change	8.18%	-4.69%	-13.96%
Operating Profit	$5.340M	-$9.707M	$14.20M
YoY Change	-65.01%	-168.37%	3706.43%
Interest Expense	-$1.510M	-$1.470M	-$2.260M
YoY Change	-37.08%	-34.96%	-2360.0%
% of Operating Profit	-28.28%		-15.92%
Other Income/Expense, Net	$0.00	$1.000K	$127.0K
YoY Change	-100.0%	-99.21%
Pretax Income	-$17.60M	-$19.38M	$12.07M
YoY Change	142.42%	-260.56%	2457.2%
Income Tax	-$1.020M	$38.00K	-$309.0K
% Of Pretax Income			-2.56%
Net Earnings	-$16.58M	-$19.42M	$12.38M
YoY Change	121.78%	-256.85%	-7054.49%
Net Earnings / Revenue	-24.19%	-30.2%	13.93%
Basic Earnings Per Share	-$0.17	-$0.48	$0.12
Diluted Earnings Per Share	-$0.17	-$0.48	$0.11
COMMON SHARES
Basic Shares Outstanding	111.0M shares	108.5M shares	107.2M shares
Diluted Shares Outstanding		108.5M shares	109.6M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$95.80M	$109.6M	$94.10M
YoY Change	38.64%	16.47%
Cash & Equivalents	$95.81M	$109.6M	$94.10M
Short-Term Investments
Other Short-Term Assets	$3.371M	$5.469M	$3.739M
YoY Change	-44.35%	46.27%
Inventory	$10.36M	$11.02M	$12.03M
Prepaid Expenses	$5.605M
Receivables	$35.42M	$33.04M	$21.39M
Other Receivables	$10.10M	$10.90M	$800.0K
Total Short-Term Assets	$160.6M	$171.5M	$134.0M
YoY Change	30.32%	27.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.44M	$10.26M	$13.18M
YoY Change	-7.23%	-22.19%
Goodwill	$19.98M	$19.98M	$19.98M
YoY Change	0.0%	0.0%
Intangibles	$6.004M	$7.168M	$7.952M
YoY Change	-22.8%	-9.86%
Long-Term Investments
YoY Change
Other Assets	$375.0K	$420.0K	$507.0K
YoY Change	-15.35%	-17.16%
Total Long-Term Assets	$41.42M	$41.85M	$45.27M
YoY Change	-5.71%	-7.55%
TOTAL ASSETS
Total Short-Term Assets	$160.6M	$171.5M	$134.0M
Total Long-Term Assets	$41.42M	$41.85M	$45.27M
Total Assets	$202.0M	$213.3M	$179.3M
YoY Change	20.86%	19.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.765M	$9.049M	$9.420M
YoY Change	0.63%	-3.94%
Accrued Expenses	$30.46M	$28.36M	$37.44M
YoY Change	-5.29%	-24.24%
Deferred Revenue	$554.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$3.750M
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$59.16M	$57.30M	$73.40M
YoY Change	-12.12%	-21.94%
LONG-TERM LIABILITIES
Long-Term Debt	$47.70M	$47.63M	$62.17M
YoY Change	-22.95%	-23.4%
Other Long-Term Liabilities	$3.755M	$4.422M	$4.151M
YoY Change	6.07%	6.53%
Total Long-Term Liabilities	$51.45M	$52.05M	$66.33M
YoY Change	-21.38%	-21.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$59.16M	$57.30M	$73.40M
Total Long-Term Liabilities	$51.45M	$52.05M	$66.33M
Total Liabilities	$110.6M	$109.3M	$139.7M
YoY Change	-16.69%	-21.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.4M	-$134.8M	-$94.66M
YoY Change	48.25%	42.44%
Common Stock	$113.0K	$113.0K	$113.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.449M	$10.72M	$9.521M
YoY Change	-31.07%	12.56%
Treasury Stock Shares	1.774M shares	2.112M shares	1.718M shares
Shareholders Equity	-$150.0K	$12.87M	$39.58M
YoY Change
Total Liabilities & Shareholders Equity	$202.0M	$213.3M	$179.3M
YoY Change	20.86%	19.0%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$16.58M	-$19.42M	$12.38M
YoY Change	121.78%	-256.85%	-7054.49%
Depreciation, Depletion And Amortization	$1.540M	$1.566M	$1.641M
YoY Change	-16.3%	-4.57%	17.21%
Cash From Operating Activities	-$10.26M	-$4.620M	-$3.160M
YoY Change	-55.62%	46.2%	-193.22%
INVESTING ACTIVITIES
Capital Expenditures	-$2.280M	-$710.0K	-$280.0K
YoY Change	188.61%	153.57%	-88.71%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$2.330M
YoY Change		-100.0%	7666.67%
Cash From Investing Activities	-$2.280M	-$710.0K	$2.060M
YoY Change	185.0%	-134.47%	-184.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.240M	66.73M	-1.700M
YoY Change	8.77%	-4025.29%	672.73%
NET CHANGE
Cash From Operating Activities	-10.26M	-4.620M	-3.160M
Cash From Investing Activities	-2.280M	-710.0K	2.060M
Cash From Financing Activities	-1.240M	66.73M	-1.700M
Net Change In Cash	-13.78M	61.40M	-2.800M
YoY Change	-45.01%	-2292.86%	-488.89%
FREE CASH FLOW
Cash From Operating Activities	-$10.26M	-$4.620M	-$3.160M
Capital Expenditures	-$2.280M	-$710.0K	-$280.0K
Free Cash Flow	-$7.980M	-$3.910M	-$2.880M
YoY Change	-64.26%	35.76%	-149.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2020Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	100000	shares
CY2019Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2019Q3	us-gaap	Lease Cost LeaseCost	300000	USD
CY2019Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3400000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	dei	Document Transition Report DocumentTransitionReport	false
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
	dei	Entity File Number EntityFileNumber	001-35887
	dei	Entity Registrant Name EntityRegistrantName	MIMEDX GROUP, INC.
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1775 West Oak Commons Ct NE
	dei	Entity Address City Or Town EntityAddressCityOrTown	Marietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Central Index Key EntityCentralIndexKey	0001376339
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	mdxg	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	11300000	USD
CY2019Q3	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	200000	USD
	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	700000	USD
CY2020Q2	mdxg	Repaymentof Payroll Protection Program Loan RepaymentofPayrollProtectionProgramLoan	10000000	USD
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	112703926	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110818649	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110591734	shares
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3540000	USD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2792552
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30062
CY2020Q3	us-gaap	Liabilities Liabilities	109346000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	132768000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	91108000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	113000	USD
	dei	City Area Code CityAreaCode	770
	dei	Local Phone Number LocalPhoneNumber	651-9100
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	MDXG
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	113000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158318000	USD
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111045418	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12870000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109595000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69069000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33042000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	34398000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	213324000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32327000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	167166000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7777000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11023000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64303000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	222855000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9104000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1492000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6669000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	420000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	443000	USD
CY2020Q3	us-gaap	Assets Assets	213324000	USD
CY2019Q4	us-gaap	Assets Assets	167166000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	9049000	USD
CY2020Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8710000	USD
CY2020Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1885277	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2112192	shares
	dei	Document Type DocumentType	10-Q
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18528000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	21302000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28363000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	61906000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4422000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88863000	USD
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	10853000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	5469000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6058000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	171474000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179686000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	123245000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10255000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12328000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4031000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3397000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	19976000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32161000	USD
CY2020Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3750000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1357000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	19976000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7168000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1399000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	57297000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	67322000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47627000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134844000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102140000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	147231000	USD
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	10717000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10806000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10289000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13205000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28513000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30372000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	54014000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	75658000	USD
	us-gaap	Gross Profit GrossProfit	151173000	USD
	us-gaap	Gross Profit GrossProfit	192483000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48046000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	51258000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	132316000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152761000	USD
CY2020Q3	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	12027000	USD
CY2019Q3	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	7242000	USD
	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	39065000	USD
	mdxg	Investigation Restatementand Related InvestigationRestatementandRelated	46374000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3372000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2691000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8281000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8421000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	276000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	269000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	818000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	769000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	446000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-9707000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	14198000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29307000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16288000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8201000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8201000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1472000	USD
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2255000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6433000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2313000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	127000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	272000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-19379000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12070000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-43943000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18329000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-309000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11239000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-225000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-19417000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	12379000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18104000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51982000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12379000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65269000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18104000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108493208	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107157561	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108222419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106929643	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108493208	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109590008	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108222419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106929643	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	22860000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32954000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	31568000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8048000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	72000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	79000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-19417000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12870000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	24684000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2685000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2019Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	173000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	12379000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	39575000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	34398000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	32954000	USD
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	31568000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11829000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2409000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32704000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	370000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	17382000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11452000	USD
	mdxg	Bad Debt Expense BadDebtExpense	0	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12870000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	49655000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9198000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1282000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18104000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	39575000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18104000	USD
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9199000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8201000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Depreciation Depreciation	4494000	USD
	us-gaap	Depreciation Depreciation	4981000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	818000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	769000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1811000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	752000	USD
	mdxg	Bad Debt Expense BadDebtExpense	616000	USD
	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	702000	USD
	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	714000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-171000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	413000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-318000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1258000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1331000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1748000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3539000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-5177000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4778000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	10835000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	389000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1633000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3515000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5444000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	339000	USD
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	209000	USD
	mdxg	Paymentsfor Application Costs Patent PaymentsforApplicationCostsPatent	370000	USD
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	83872000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-2775000	USD
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1948000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4835000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5596000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-840000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1825000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19996000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16290000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	2073000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1055000	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	2722000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2282000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1297000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	370000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	108000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2409000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1283000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2782000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6640000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	59500000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	72750000	USD
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	938000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	1439000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
	mdxg	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	100000000	USD
	mdxg	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6564000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62804000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63997000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40526000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49004000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69069000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45118000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109595000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94122000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q3	mdxg	Income Tax Receivable Cares Act IncomeTaxReceivableCARESAct	11300000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP. Conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported unaudited condensed consolidated statements of operations during the reporting period. Actual results could differ from those estimates. Significant estimates include estimated useful lives and potential impairment of property and equipment and intangible assets, estimates for contingent liabilities, the measurement of right-of-use assets and lease liabilities, management’s assessment of the Company’s ability to continue as a going concern, estimates of fair value of share-based payments, and valuation of deferred tax assets.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In addition to the above, the Company has considered the potential effects of the COVID-19 Pandemic with respect to determinations surrounding impairments, increases in allowances for credit losses, other expenses, and changes in accounting judgments that have or are reasonably likely to have a material impact on the unaudited condensed consolidated financial statements.</span></div>
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	600000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	USD
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reporting_unit
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q3	mdxg	Amounts Invoicedand Not Collected After Transition Adjustment AmountsInvoicedandNotCollectedAfterTransitionAdjustment	1800000	USD
CY2019Q4	mdxg	Amounts Invoicedand Not Collected After Transition Adjustment AmountsInvoicedandNotCollectedAfterTransitionAdjustment	9000000.0	USD
CY2020Q3	mdxg	Deferred Costof Sales After Transition Adjustment DeferredCostofSalesAfterTransitionAdjustment	200000	USD
CY2019Q4	mdxg	Deferred Costof Sales After Transition Adjustment DeferredCostofSalesAfterTransitionAdjustment	1300000	USD
CY2019Q3	mdxg	Amounts Invoicedand Not Collected After Transition Adjustment AmountsInvoicedandNotCollectedAfterTransitionAdjustment	48883000	USD
CY2019Q3	mdxg	Deferred Costof Sales After Transition Adjustment DeferredCostofSalesAfterTransitionAdjustment	6415000	USD
CY2019Q4	mdxg	Amounts Invoicedand Not Collected After Transition Adjustment AmountsInvoicedandNotCollectedAfterTransitionAdjustment	9006000	USD
CY2019Q4	mdxg	Deferred Costof Sales After Transition Adjustment DeferredCostofSalesAfterTransitionAdjustment	1261000	USD
CY2020Q3	mdxg	Amounts Invoicedand Not Collected After Transition Adjustment AmountsInvoicedandNotCollectedAfterTransitionAdjustment	1766000	USD
CY2020Q3	mdxg	Deferred Costof Sales After Transition Adjustment DeferredCostofSalesAfterTransitionAdjustment	247000	USD
	mdxg	Group Purchasing Organization Administrative Feesas Percentof Purchase Volume GroupPurchasingOrganizationAdministrativeFeesasPercentofPurchaseVolume	0.03
	mdxg	Capitalized Patent Application Costs CapitalizedPatentApplicationCosts	200000	USD
	mdxg	Capitalized Patent Application Costs CapitalizedPatentApplicationCosts	400000	USD
CY2020Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	426000	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	318000	USD
CY2020Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	5241000	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4299000	USD
CY2020Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5904000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5206000	USD
CY2020Q3	us-gaap	Inventory Gross InventoryGross	11571000	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	9823000	USD
CY2020Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	548000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	719000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	11023000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	9104000	USD
CY2020Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	3400000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	38494000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36305000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28239000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23977000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10255000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12328000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	1566000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	1641000	USD
	us-gaap	Depreciation Depreciation	4494000	USD
	us-gaap	Depreciation Depreciation	4981000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	1100000	USD
CY2020Q3	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	400000	USD
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	1200000	USD
CY2019Q3	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	400000	USD
	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	1300000	USD
CY2020Q3	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	200000	USD
	mdxg	Operating Lease Rightofuse Asset Amortization OperatingLeaseRightofuseAssetAmortization	700000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4031000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3397000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1139000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1168000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3452000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2919000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.115
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	426000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1544000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1568000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	577000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	377000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1200000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5692000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1101000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4591000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14663000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9573000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5090000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14394000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8755000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	818000	USD
CY2020Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5639000	USD
CY2020Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16741000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7168000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	16532000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7777000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	276000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	269000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	769000	USD
CY2019Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0.0	USD
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	800000	USD
CY2019Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0.0	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	500000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	274000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1034000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	933000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	933000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	933000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	983000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5090000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	15094000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	12202000	USD
CY2020Q3	mdxg	Accrued Settlement Costs Current AccruedSettlementCostsCurrent	7575000	USD
CY2019Q4	mdxg	Accrued Settlement Costs Current AccruedSettlementCostsCurrent	5931000	USD
CY2020Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0	USD
CY2019Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	6894000	USD
CY2020Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	827000	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	2581000	USD
CY2020Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1625000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1722000	USD
CY2020Q3	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	952000	USD
CY2019Q4	mdxg	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	1076000	USD
CY2020Q3	mdxg	Accrued Rebates AccruedRebates	1295000	USD
CY2019Q4	mdxg	Accrued Rebates AccruedRebates	142000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	995000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1613000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28363000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32161000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	50000000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	50000000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8200000	USD
CY2020Q2	mdxg	Proceedsfrom Payroll Protection Program Loan ProceedsfromPayrollProtectionProgramLoan	10000000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-19417000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	12379000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32704000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-18104000	USD
CY2020Q3	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	997000	USD
CY2019Q3	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	0	USD
	mdxg	Temporary Equity Accretedbut Unrecorded Dividends TemporaryEquityAccretedbutUnrecordedDividends	997000	USD
CY2020Q3	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	31110000	USD
CY2019Q3	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	0	USD
	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	31110000	USD
	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	0	USD
CY2020Q3	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	458000	USD
CY2019Q3	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	USD
	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	458000	USD
	mdxg	Temporary Equity Accretionof Increasingrate Dividend Feature TemporaryEquityAccretionofIncreasingrateDividendFeature	0	USD
CY2020Q3	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	32565000	USD
CY2019Q3	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	32565000	USD
	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51982000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12379000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65269000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18104000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108493208	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107157561	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108222419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106929643	shares
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51982000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12379000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-65269000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18104000	USD
CY2020Q3	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	32565000	USD
CY2019Q3	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	32565000	USD
	mdxg	Adjustmentsto Reconcileto Net Income Loss Availableto Common Stockholders AdjustmentstoReconciletoNetIncomeLossAvailabletoCommonStockholders	0	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-51982000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12379000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-65269000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-18104000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108493208	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107157561	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108222419	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106929643	shares
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28625684	shares
CY2019Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2432447	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11032820	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1635797	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108493208	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109590008	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108222419	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106929643	shares
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28625684	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2432447	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11032820	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1635797	shares
CY2020Q3	mdxg	Debt Instrument Convertible Beneficial Conversion Feature Amortization DebtInstrumentConvertibleBeneficialConversionFeatureAmortization	31100000	USD
CY2020Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2019Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.026
CY2020Q3	mdxg	Effective Income Tax Rate Reconciliation Discrete Items EffectiveIncomeTaxRateReconciliationDiscreteItems	0	USD
CY2019Q3	mdxg	Effective Income Tax Rate Reconciliation Discrete Items EffectiveIncomeTaxRateReconciliationDiscreteItems	300000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.256
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
	mdxg	Effective Income Tax Rate Reconciliation Discrete Items EffectiveIncomeTaxRateReconciliationDiscreteItems	11400000	USD
	mdxg	Effective Income Tax Rate Reconciliation Discrete Items EffectiveIncomeTaxRateReconciliationDiscreteItems	300000	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	11300000	USD
	mdxg	Effective Income Tax Rate Reconciliation Net Operating Loss Carryforward EffectiveIncomeTaxRateReconciliationNetOperatingLossCarryforward	0	USD
	us-gaap	Interest Paid InterestPaid	6308000	USD
	us-gaap	Interest Paid InterestPaid	2417000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	213000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	308000	USD
	mdxg	Noncash Activities Deferred Financing Costs NoncashActivitiesDeferredFinancingCosts	471000	USD
	mdxg	Noncash Activities Deferred Financing Costs NoncashActivitiesDeferredFinancingCosts	0	USD
	mdxg	Stock Issuance Costs Incurred StockIssuanceCostsIncurred	942000	USD
	mdxg	Stock Issuance Costs Incurred StockIssuanceCostsIncurred	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	0	USD
	mdxg	Noncash Activities Debt Instrument Amendment Fee NoncashActivitiesDebtInstrumentAmendmentFee	722000	USD
	mdxg	Noncash Activities Debt Instrument Amendment Fee NoncashActivitiesDebtInstrumentAmendmentFee	0	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	300000	USD
	us-gaap	Lease Cost LeaseCost	1000000.0	USD
	us-gaap	Lease Cost LeaseCost	1100000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	222855000	USD
CY2020Q3	mdxg	Accrued Settlement Costs Current AccruedSettlementCostsCurrent	7600000	USD
	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	7400000	USD
CY2020Q3	mdxg	Numberof Distribution Channels NumberofDistributionChannels	2	distribution_channel
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	64303000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88863000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179686000	USD

Files In Submission

Name	View Source	Status
0001376339-20-000147-index-headers.html	Edgar Link	pending
0001376339-20-000147-index.html	Edgar Link	pending
0001376339-20-000147.txt	Edgar Link	pending
0001376339-20-000147-xbrl.zip	Edgar Link	pending
ex103kashyapofferlette.htm	Edgar Link	pending
ex104steinrobertofferl.htm	Edgar Link	pending
ex104steinrobertoffer_image1.jpg	Edgar Link	pending
ex105formofnon-employe.htm	Edgar Link	pending
exhibit311-ceosec302x2.htm	Edgar Link	pending
exhibit312-cfosec302x2.htm	Edgar Link	pending
exhibit321-ceosec906x2.htm	Edgar Link	pending
exhibit322-cfosec906x2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mdxg-20200930.xsd	Edgar Link	pending
mdxg-20200930_cal.xml	Edgar Link	unprocessable
mdxg-20200930_def.xml	Edgar Link	unprocessable
mdxg-20200930_lab.xml	Edgar Link	unprocessable
mdxg-20200930_pre.xml	Edgar Link	unprocessable
mdxg-2020930x10xq.htm	Edgar Link	pending
mdxg-2020930x10xq_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDXG
MIMEDX GROUP, INC. Stock $mdxg

2020 Q4 Form 10-Q Financial Statement

#000137633920000147 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG MIMEDX GROUP, INC. Stock $mdxg

2020 Q4 Form 10-Q Financial Statement

#000137633920000147 Filed on November 04, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDXG
MIMEDX GROUP, INC. Stock $mdxg